Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis

被引：0

作者：

Vivian P. Bykerk

Gerd R. Burmester

Bernard G. Combe

Daniel E. Furst

Tom W. J. Huizinga

Harris A. Ahmad

Paul Emery

机构：

[1] Weill Cornell Medical College,Department of Rheumatology, Hospital for Special Surgery

[2] Charité–University Medicine Berlin,Department of Rheumatology and Clinical Immunology

[3] Service d’Immuno-Rheumatologie,Department of Rheumatology

[4] University of California Los Angeles,Department of Medicine

[5] Leiden University Medical Center,Department of Rheumatology

[6] Bristol-Myers Squibb,Headquarters Medical Immunology

[7] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine

[8] Leeds Teaching Hospitals NHS Trust,NIHR Leeds Musculoskeletal Biomedical Research Unit

来源：

Rheumatology International | 2019年 / 39卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The article “On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis”, written by Vivian P.Bykerk, was originally published Online First without open access.

引用

页码：945 / 945

共 50 条

[41] Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis
Irazú Contreras-Yáñez
Guillermo Arturo Guaracha-Basáñez
Maximiliano Cuevas-Montoya
José de Jesús Hernández-Bautista
Virginia Pascual-Ramos
Arthritis Research & Therapy, 24
[42] Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?
Liu, Di
Yuan, Na
Yu, Guimei
Song, Ge
Chen, Yan
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (08): : 3758 - 3775
[43] Improved outcomes of drug-free remission with DAS-steered therapy compared to conventional therapy for rheumatoid arthritis
van der Woude, D.
Visser, K.
Brand, R.
Klarenbeek, N. B.
van der Linden, M. P. M.
Mailee, C.
de Beus, W. M.
Kerstens, P. J. S. M.
Dijkmans, B. A. C.
Huizinga, T. W. J.
Mil, A. H. M. van der Helm-van
Allaart, C. F.
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S919 - S920
[44] Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study (vol 105, 102298, 2019)
Baker, Kenneth F.
Skelton, Andrew J.
Lendrem, Dennis W.
Scadeng, Adam
Thompson, Ben
Pratt, Arthur G.
Isaacs, John D.
JOURNAL OF AUTOIMMUNITY, 2022, 132
[45] CONCOMITANT USE OF CORTICOSTEROIDS AT THE BASELINE DOES NOT AFFECT THE DRUG SURVIVAL OF ABATACEPT IN RHEUMATOID ARTHRITIS
Koca, S. S.
Oz, B.
Karatas, A.
Dalkilic, H. E.
Can, G.
Pehlivan, Y.
Senel, S.
Yazici, A.
Inanc, N.
Cefle, A.
Erturk, Z.
Akar, S.
Yagiz, B.
Goker, B.
Birlik, A. M.
Onen, F.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 597 - 597
[46] Methotrexate in early rheumatoid arthritis: Is the anchor drug still holding?
Giollo, Alessandro
Fuzzi, Enrico
Doria, Andrea
AUTOIMMUNITY REVIEWS, 2022, 21 (04)
[47] Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova et al
Zeidler, Henning
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07)
[48] Prevalence of and Predictive Factors for Sustained Disease-Modifying Antirheumatic Drug-Free Remission in Rheumatoid Arthritis Results From Two Large Early Arthritis Cohorts
van der Woude, Diane
Young, Adam
Jayakumar, Keeranur
Mertens, Bart J.
Toes, Rene E. M.
van der Heijde, Desiree
Huizinga, Tom W. J.
van der Helm-van Mil, Annette H. M.
ARTHRITIS AND RHEUMATISM, 2009, 60 (08): : 2262 - 2271
[49] Sustained drug-free remission and persistent hypogammaglobulinemia in a patient with rheumatoid arthritis three years after discontinuing Rituximab treatment
Krasselt, M.
Baerwald, C.
Seifert, O.
ACTA REUMATOLOGICA PORTUGUESA, 2021, 46 (02): : 190 - 191
[50] Can we achieve true drug-free remission in patients with RA?
Yvonne P. M. Goekoop-Ruiterman
Tom W. J. Huizinga
Nature Reviews Rheumatology, 2010, 6 : 68 - 70

← 1 2 3 4 5 →